| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9576 | 
      | Human Intestinal Absorption | HIA+ | 0.9794 | 
      | Caco-2 Permeability | Caco2+ | 0.5115 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8900 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9874 | 
                                                     | Non-inhibitor | 0.9945 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9513 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7932 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8562 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9022 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.8114 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8806 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9278 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9526 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9389 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9823 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9764 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9509 | 
                                                                    | Non-inhibitor | 0.9894 | 
      | AMES Toxicity | Non AMES toxic | 0.9308 | 
      | Carcinogens | Carcinogens  | 0.5057 | 
      | Fish Toxicity | High FHMT | 0.6893 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.8974 | 
      | Honey Bee Toxicity | High HBT | 0.8325 | 
      | Biodegradation | Ready biodegradable | 0.9704 | 
      | Acute Oral Toxicity | III | 0.3687 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6401 |